The Anti-Inflammatory Effect of Opioids
Authors:
- 1 January 1994
- journal article
- research article
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 74 (1-4) , 259-264
Abstract
The anti-inflammatory activity of two novel opioids PM and PO as well as of pethidine was studied. The mouse paw edema, induced by various phlogistic agents, was significantly inhibited after the administration of opioids, fact that was independent of their antioxidant properties. The anti-inflammatory action of the above opioids was not reversed by naloxone. These results suggest that a variety of complex regulatory activities may be performed by opioid agonists via naloxone-sensitive or naloxone insensitive receptors on inflammatory cells, directly or indirectly by the inhibition of cytokines and mediators involved in inflammation.Keywords
This publication has 13 references indexed in Scilit:
- Suppression of Adjuvant‐Induced Disease (AID) by a Novel Analgesic‐Opioid Agonist Which Also Possesses Antioxidant Activity (Neuroimmunomodulation)Annals of the New York Academy of Sciences, 1992
- Inhibition by opioids of phagocytosis in peritoneal macrophagesNeuropeptides, 1991
- Suppression of experimental autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibitionActa Neurologica Scandinavica, 1989
- Synthesis, physicochemical properties and biological studies of some substituted 2-alkoxy-4-methyl-morpholinesEuropean Journal of Medicinal Chemistry, 1989
- Opioid binding site in EL-4 thymoma cell lineLife Sciences, 1988
- Recent Advances in the Management of TicsClinical Neuropharmacology, 1986
- Lipid peroxidation modified the effect of phenolic anti-inflammatory drugs on prostaglandin biosynthesisBiochemical Pharmacology, 1985
- B-endorphin modulates human immune activity via non-opiate receptor mechanismsLife Sciences, 1982
- Specific Nonopiate Receptors for β-EndorphinScience, 1979
- Biological properties of carrageenanJournal of Pharmacy and Pharmacology, 1972